Abstract
Background and Purpose: Subarachnoid hemorrhage (SAH) is a severe disease characterized by sudden headache, loss of consciousness, or focal neurological deficits. Melatonin has been reported as a potential neuroprotective agent of SAH. It provides protective effects through the anti-inflammatory effects or the autophagy pathway. Our systematic review aims to evaluate the efficacy of melatonin administration on experimental SAH animals and offer support for the future clinical trial design of the melatonin treatment following SAH.Methods: The following online databases were searched for experimentally controlled studies of the effect of melatonin on SAH models: PubMed, Web of Knowledge, Embase, and China National Knowledge Infrastructure (all until March 2021). The melatonin effect on the brain water content (BWC) and neurological score (NS) were compared between the treatment and control groups using the standardized mean difference (SMD).Results: Our literature identified 160 possible articles, and most of them were excluded due to duplication (n = 69) and failure to meet the inclusion criteria (n = 56). After screening the remaining 35 articles in detail, we excluded half of them because of no relevant outcome measures (n = 16), no relevant interventions (n = 3), review articles (n = 1), duplicated publications (n = 1), and studies on humans or cells (n = 2). Finally, this systematic review contained 12 studies between 2008 and 2018. All studies were written in English except for one study in Chinese, and all of them showed the effect of melatonin on BWC and NS in SAH models.Conclusion: Our research shows that melatonin can significantly improve the behavior and pathological results of SAH animal models. However, due to the small number of studies included in this meta-analysis, the experimental design and experimental method limitations should be considered when interpreting the results. Significant clinical and animal studies are still required to evaluate whether melatonin can be used in the adjuvant treatment of clinical SAH patients.
Highlights
It only leads to 4.4% of all types of strokes, subarachnoid hemorrhage (SAH) is a severe disease with high mortality and morbidity [1]
The results show that methodological differences including modeling methods, anesthetic drugs, the dosage of melatonin, and dose administration have contributed to the heterogeneity of the results
Our results showed that isoflurane achieved the best effect in both the brain water content and neurobehavioral score groups, but the results are less reliable considering the small sample size
Summary
It only leads to 4.4% of all types of strokes, subarachnoid hemorrhage (SAH) is a severe disease with high mortality and morbidity [1]. SAH is characterized by clinical features such as sudden headache, single or combined with vomiting, loss of consciousness, or focal neurological deficits [2]. Activation of the MAPK (mitogenactivated protein kinase) and Keap1-Nrf2-ARE [(Kelch-like ECH-Associating protein 1) nuclear factor erythroid 2 related factor 2-antioxidant response element] pathways may take over part of the inflammatory damage mechanism [8, 9]. The EBI following SAH can be induced by the autophagy mechanism [10], with the activation of mitochondria and the downstream pathway [11]. Subarachnoid hemorrhage (SAH) is a severe disease characterized by sudden headache, loss of consciousness, or focal neurological deficits. Melatonin has been reported as a potential neuroprotective agent of SAH. It provides protective effects through the anti-inflammatory effects or the autophagy pathway.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
